On Friday, Wayfair Inc (NYSE:W)’s shares declined -6.51% to $30.03.
Wayfair Inc (W) declared that it will release financial results for its first quarter ended March 31, 2015 before the opening of the market on Monday, May 11, 2015.
Wayfair will host a conference call at 8 a.m. (ET) on May 11 to review results.
Wayfair Inc. engages in the e-commerce business in the United States. It offers about seven million home products under various brands.
Bill Barrett Corporation (NYSE:BBG)’s shares dropped -6.21% to $10.88.
Bill Barrett Corporation (BBG) plans to release its first quarter 2015 financial and operating results before the market opens on Friday, May 8, 2015 and to host a conference call later that morning.
Bill Barrett Corporation, an independent energy company, acquires, explores for, and develops oil and natural gas resources in the United States. It primarily holds interests in the Denver-Julesburg basin, the Uinta oil program in the Uinta Basin, and the Gibson Gulch area in the Piceance basin in the Rocky Mountain region of the United States.
At the end of Friday’s trade, Rovi Corporation (NASDAQ:ROVI)‘s shares dipped -5.73% to $17.45.
Rovi Corporation (ROVI) declared that its Board of Directors has approved new compensation arrangements reducing overall compensation for its outside directors. Under the new arrangements, the outside directors’ 2015 total direct compensation has been reduced to the 50th percentile of Rovi’s peer group. Both cash retainers and equity compensation payments are being reduced. The new arrangements are effective right away for 2015.
Rovi Corporation provides integrated solutions for the discovery and personalization of digital entertainment to service providers and consumer electronics (CE) industry worldwide.
Tekmira Pharmaceuticals Corp (NASDAQ:TKMR), ended its Friday’s trading session with -5.17% loss, and closed at $14.67.
Tekmira Pharmaceuticals Corp (TKMR) declared that Mr. Pat Higgins, Tekmira’s Chief Operating Officer and Dr. William Symonds, Tekmira’s Chief Development Officer will take part in an analyst-led fireside chat at the 40th Annual Deutsche Bank Health Care Conference on Thursday, May 7, 2015 at 8.20am-8.55am (PT) / 11.20am-11.55am (ET) at the InterContinental Boston Hotel, Boston, MA.
Tekmira Pharmaceuticals Corporation, a biopharmaceutical company, focuses on the research and development of RNA interference therapeutics; and provides lipid nanoparticle delivery technology to pharmaceutical partners in Canada.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
